α-Synuclein and Parkinsonism: Updates and Future Perspectives
- PMID: 28324300
- DOI: 10.1007/s11910-017-0737-y
α-Synuclein and Parkinsonism: Updates and Future Perspectives
Abstract
Mutations in the SNCA gene, which encodes the α-synuclein protein, were the first discovered genetic causes of familial parkinsonism with Lewy pathology. To date, six different SNCA missense mutations as well as multiplications are known to cause parkinsonism. For this review, we performed a literature search to identify all published cases of SNCA-related parkinsonism to provide an updated summary of the clinical and neuropathological features of parkinsonism due to SNCA mutations. Familial parkinsonism associated with SNCA is rare, but α-synuclein aggregation is a core feature of sporadic parkinsonism, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Research into α-synuclein and parkinsonism has impacted how we define the pathology and understand the pathogenesis of Parkinson's disease and related neurodegenerative disorders. We briefly discuss some of the lessons we have learned from research into the physiological role of α-synuclein and its pathological links to neurodegeneration and parkinsonism.
Keywords: Dementia with Lewy bodies; Lewy pathology; Multiple system atrophy; Parkinson’s disease; Phenotype; SNCA.
Similar articles
-
Link between the SNCA gene and parkinsonism.Neurobiol Aging. 2015 Mar;36(3):1505-18. doi: 10.1016/j.neurobiolaging.2014.10.042. Epub 2014 Dec 3. Neurobiol Aging. 2015. PMID: 25554495 Review.
-
[Relationship between alpha-synuclein and Parkinson's disease].Brain Nerve. 2007 Aug;59(8):825-30. Brain Nerve. 2007. PMID: 17713118 Review. Japanese.
-
Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.Neuron. 2006 Oct 5;52(1):33-8. doi: 10.1016/j.neuron.2006.09.026. Neuron. 2006. PMID: 17015225 Review.
-
Autosomal dominant Parkinson's disease caused by SNCA duplications.Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1(Suppl 1):S1-6. doi: 10.1016/j.parkreldis.2015.09.007. Epub 2015 Sep 3. Parkinsonism Relat Disord. 2016. PMID: 26350119 Free PMC article. Review.
-
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.Lancet Neurol. 2019 Aug;18(8):748-759. doi: 10.1016/S1474-4422(19)30140-1. Epub 2019 Jun 19. Lancet Neurol. 2019. PMID: 31229470
Cited by
-
Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology.Mov Disord. 2020 Feb;35(2):256-267. doi: 10.1002/mds.27887. Epub 2019 Oct 23. Mov Disord. 2020. PMID: 31643109 Free PMC article.
-
Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein.Acta Neuropathol Commun. 2020 Feb 14;8(1):17. doi: 10.1186/s40478-020-0894-0. Acta Neuropathol Commun. 2020. PMID: 32059750 Free PMC article.
-
Alpha-Synuclein in Alcohol Use Disorder, Connections with Parkinson's Disease and Potential Therapeutic Role of 5' Untranslated Region-Directed Small Molecules.Biomolecules. 2020 Oct 21;10(10):1465. doi: 10.3390/biom10101465. Biomolecules. 2020. PMID: 33096655 Free PMC article. Review.
-
Cognitive Impairment in Genetic Parkinson's Disease.Parkinsons Dis. 2021 Dec 30;2021:8610285. doi: 10.1155/2021/8610285. eCollection 2021. Parkinsons Dis. 2021. PMID: 35003622 Free PMC article. Review.
-
Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease.Parkinsons Dis. 2021 Nov 23;2021:6318067. doi: 10.1155/2021/6318067. eCollection 2021. Parkinsons Dis. 2021. PMID: 34858569 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous